Infection Surveillance Solution Market - Global Forecast 2025-2032

The Infection Surveillance Solution Market is emerging as a cornerstone of healthcare technology, with leadership teams prioritizing platforms that deliver operational resilience, regulatory compliance, and robust real-time data integration to address complex infection control challenges.

Market Snapshot: Infection Surveillance Solution Market Growth and Trends

The Infection Surveillance Solution Market is demonstrating substantial growth, with expansion projected from USD 867.99 million in 2024 to USD 985.81 million in 2025, and a compound annual growth rate (CAGR) of 13.80% anticipated through 2032. This upward momentum is fueled by increased attention to healthcare-associated infection (HAI) control, the rise of real-time analytics, and the adoption of advanced cloud-driven frameworks. Escalating concerns about antimicrobial resistance and the frequency of outbreaks are prompting providers to implement integrated surveillance infrastructures. Demand is consolidating around platforms capable of merging clinical, laboratory, and environmental datasets, enabling earlier detection and coordinated responses.

Scope & Segmentation

This report offers an in-depth examination of the Infection Surveillance Solution Market, providing strategic, actionable intelligence across solution categories, deployment strategies, technological progress, and regional markets. Segment analysis highlights the following:

• Component: Services, including consulting, implementation and integration, maintenance and upgrades, and training and support, as well as software solutions encompassing alert management, data analytics, and reporting and visualization.
• Deployment Mode: Options such as cloud (hybrid, private, and public clouds) and on-premises setups (dedicated servers and virtualization) are addressed to meet a spectrum of data governance and security requirements.
• Technology: The landscape encompasses artificial intelligence and machine learning (for both supervised and unsupervised learning), Internet of Things (IoT) and sensor-based platforms, and traditional rule-based systems.
• Application: Use cases include infection control and HAI surveillance (covering bloodstream, surgical site, and urinary tract infections), outbreak management (case identification, contact tracing, resource allocation), pathogen genomics analysis, and syndromic surveillance.
• End User: Primary stakeholders span diagnostic labs, hospitals, public health agencies, and research institutes, each requiring unique workflow integrations and support models.
• Geographical Coverage: The report addresses opportunities and competitive landscapes across the Americas (North America and Latin America), Europe, the Middle East and Africa, and the Asia-Pacific region, capturing the distinct regulatory and technological maturity levels found in each market.
• Company Profiles: Profiles of key suppliers such as Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Abbott Laboratories, Siemens Healthineers AG, Sysmex Corporation, Bio-Rad Laboratories, Inc., QIAGEN N.V., and Agilent Technologies, Inc. are included, mapping their market strategies and innovation priorities.

Key Takeaways for Senior Decision-Makers

• Integration of digital health platforms and real-time data analytics is streamlining infection detection and response, strengthening network-wide situational awareness for healthcare organizations.
• Unified data platforms are driving competitive differentiation; vendors are leveraging artificial intelligence, cloud computing, and genomic technologies to create actionable insights tailored for infection control and outbreak management.
• Strategic partnerships between technology developers and research centers are elevating both platform breadth and the specialization required for emerging infection threats.
• Regional deployment is influenced by varying regulatory landscapes and digital infrastructure maturity, requiring adaptable and interoperable solution architectures.
• End users prioritize modular and customizable software, paired with reliable service support, to mitigate operational risk and accelerate technology adoption cycles.
• Interdisciplinary governance models ensure that evolving surveillance practices remain aligned with clinical, operational, and compliance imperatives.

Tariff Impact on Infection Surveillance Solution Market

Recent tariffs imposed in the United States on imported medical hardware and software components are reshaping procurement strategies, increasing costs for both solution providers and healthcare buyers. Consequently, market participants are turning toward nearshoring and local manufacturing collaborations to safeguard supply continuity. In addition, flexible procurement and service agreements—such as escalation clauses and fixed-fee arrangements—are being adopted to address supply chain volatility and maintain operational stability.

Methodology & Data Sources

The report employs a comprehensive multi-method approach, drawing on primary interviews with epidemiology experts, laboratory supervisors, and technology providers. Secondary sources, such as regulatory documentation, technical literature, and case studies from industry pilot programs, are used to consolidate insights. Quantitative results are cross-validated using vendor-reported data and benchmarking analyses to ensure integrity.

Why This Report Matters

• Delivers actionable, evidence-based insights on emerging technology and evolving regulatory requirements, empowering informed investment, partnership, and research decisions for healthcare leaders.
• Streamlines the vendor selection process by aligning procurement decisions with critical factors such as interoperability, long-term support, and infrastructure adaptability.
• Guides deployment strategies to support organizational priorities—such as patient safety, operational efficiency, and cost management—in a shifting risk landscape.

Conclusion

The Infection Surveillance Solution Market’s evolution is marked by advanced technologies, dynamic alliances, and focused analytics. Access to in-depth strategic intelligence equips senior leaders to build resilient and responsive infection surveillance frameworks.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.